A randomised controlled trial of 3 strategies for the treatment of ARV-naive HIV-infected patients with tuberculosis
Shadows over the "Golden Decade": how certain HIV-infected populations have not benefitted fully from the scale-up of anti-retroviral therapy and what can be done about it
Generation of a dynamic spatial map of the cellular landscape of HIV-infected gut and its application in unraveling the role of tissue-resident T cells in HIV
Towards the clinical application of total HIV DNA: a valuable marker for the diagnosis of HIV-infected infants and treatment follow-up in HIV adults.
Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?
Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy